Literature DB >> 3271021

Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease.

J J Zambon, T Umemoto, E De Nardin, F Nakazawa, L A Christersson, R J Genco.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3271021     DOI： 10.1177/08959374880020021101

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN： 0895-9374


× No keyword cloud information.
  24 in total

1.  Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)- mediated alveolar bone destruction in vivo.

Authors:  Yen-Tung A Teng
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo.

Authors:  Yen-Tung A Teng; Deeqa Mahamed; Bhagirath Singh
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.

Authors:  Y T Teng; H Nguyen; X Gao; Y Y Kong; R M Gorczynski; B Singh; R P Ellen; J M Penninger
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

5.  Heterogeneity of Actinobacillus actinomycetemcomitans strains in various human infections and relationships between serotype, genotype, and antimicrobial susceptibility.

Authors:  S Paju; P Carlson; H Jousimies-Somer; S Asikainen
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Evaluating two methods for fingerprinting genomes of Actinobacillus actinomycetemcomitans.

Authors:  J Slots; Y B Liu; J M DiRienzo; C Chen
Journal:  Oral Microbiol Immunol       Date:  1993-12

7.  Immunochemical and structural characterization of a serotype-specific polysaccharide antigen from Actinobacillus actinomycetemcomitans Y4 (serotype b).

Authors:  K Amano; T Nishihara; N Shibuya; T Noguchi; T Koga
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Evaluation of two commercial kits and arbitrarily primed PCR for identification and differentiation of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, and Haemophilus paraphrophilus.

Authors:  B Doğan; S Asikainen; H Jousimies-Somer
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau; J Pohl; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Conjugal transfer of broad-host-range incompatibility group P and Q plasmids from Escherichia coli to Actinobacillus actinomycetemcomitans.

Authors:  P Goncharoff; J K Yip; H Wang; H C Schreiner; J A Pai; D Furgang; R H Stevens; D H Figurski; D H Fine
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.